Extracorporeal Shockwave Treatment for Greater Trochanteric Pain Syndrome

NACompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

January 21, 2019

Study Completion Date

February 18, 2019

Conditions
Mobility LimitationTrochanteric SyndromeGluteal TendinitisBursitis HipPain Syndrome
Interventions
DEVICE

Duolith SD1, STORZ Medical, Switzerland with F-SW applicator

The procedure will be performed with the patient in lateral positioning of the decubitus. The treatment area will be prepared with a coupling ultrasound gel to minimize the loss of shockwave energy at the interface between the tip of the applicator and the skin. The inline ultrasonic guide will be used to concentrate the shockwaves on the pain area in the trochanteric region. No local anesthesia will be applied.

Trial Locations (1)

00144

Sant'Andrea Hospital, Roma

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT03338465 - Extracorporeal Shockwave Treatment for Greater Trochanteric Pain Syndrome | Biotech Hunter | Biotech Hunter